FDA Pfizer is Subject of FDA’s Second Untitled Letter of 2018 Thomas Sullivan Jul 30, 2018 0 In June 2018, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent its second…
